T lymphocyte characteristics and immune repertoires in the epicardial adipose tissue of heart failure patients

Front Immunol. 2023 Mar 7:14:1126997. doi: 10.3389/fimmu.2023.1126997. eCollection 2023.

Abstract

Background: Epicardial adipose tissue (EAT) acts as an active immune organ and plays a critical role in the pathogenesis of heart failure (HF). However, the characteristics of immune cells in EAT of HF patients have rarely been elucidated.

Methods: To identify key immune cells in EAT, an integrated bioinformatics analysis was performed on public datasets. EAT samples with paired subcutaneous adipose tissue (SAT), heart, and peripheral blood samples from HF patients were collected in validation experiments. T cell receptor (TCR) repertoire was assessed by high-throughput sequencing. The phenotypic characteristics and key effector molecules of T lymphocytes in EAT were assessed by flow cytometry and histological staining.

Results: Compared with SAT, EAT was enriched for immune activation-related genes and T lymphocytes. Compared with EAT from the controls, activation of T lymphocytes was more pronounced in EAT from HF patients. T lymphocytes in EAT of HF patients were enriched by highly expanded clonotypes and had greater TCR clonotype sharing with cardiac tissue relative to SAT. Experiments confirmed the abundance of IFN-γ+ effector memory T lymphocytes (TEM) in EAT of HF patients. CCL5 and GZMK were confirmed to be associated with T lymphocytes in EAT of HF patients.

Conclusion: EAT of HF patients was characterized by pronounced immune activation of clonally expanded IFN-γ+ TEM and a generally higher degree of TCR clonotypes sharing with paired cardiac tissue.

Keywords: T lymphocytes; TCR immune repertoires; bioinformatics analyses; epicardial adipose tissue; heart failure; immune infiltration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue*
  • Heart Failure* / pathology
  • Humans
  • Pericardium / pathology
  • Receptors, Antigen, T-Cell
  • Subcutaneous Fat

Substances

  • Receptors, Antigen, T-Cell

Grants and funding

This work was supported by grants from the National Natural Science Foundation of China (No. 82030016, 82230011 to XC; No. 81974037, 82170394 to T-TT) and Hubei Key Laboratory of Biological Targeted Therapy (No. 2022swbx002 to X-ZZ). All the funders had no role in the study design, data collection, data analysis, interpretation, writing of the manuscript, or the decision to submit the paper for publication.